Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference

Go back to Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference
(NASDAQ: EDSA) Delayed: 7.35 +0.47 (6.83%)
Previous Close $6.88    52 Week High
Open $6.94    52 Week Low
Day High $7.60    P/E N/A 
Day Low $6.56    EPS
Volume 258,619